Correcting Overall Survival for the Impact of Crossover Via a Rank-Preserving Structural Failure Time (RPSFT) Model in the RECORD-1 Trial of Everolimus in Metastatic Renal-Cell Carcinoma.
Saved in:
| Title: | Correcting Overall Survival for the Impact of Crossover Via a Rank-Preserving Structural Failure Time (RPSFT) Model in the RECORD-1 Trial of Everolimus in Metastatic Renal-Cell Carcinoma. |
|---|---|
| Authors: | Korhonen, P.1 (AUTHOR) pasi.korhonen@statfinn.fi, Zuber, E.2 (AUTHOR), Branson, M.2 (AUTHOR), Hollaender, N.2 (AUTHOR), Yateman, N.3 (AUTHOR), Katiskalahti, T.1 (AUTHOR), Lebwohl, D.4 (AUTHOR), Haas, T.2 (AUTHOR) |
| Source: | Journal of Biopharmaceutical Statistics. Nov/Dec2012, Vol. 22 Issue 6, p1258-1271. 14p. 1 Diagram, 1 Chart, 4 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 10543406 |
|---|---|
| DOI: | 10.1080/10543406.2011.592233 |
